Key Points Combined, these five companies have returned over $500 billion to shareholders in the past decade while growing their dividends every single year. Yields range from Costco's modest 0.57% to Pfizer's generous 7.2%, offering options for both income seekers and growth-focused investors. Each operates with competitive moats so wide that disruption seems nearly impossible, from American Express's affluent cardholders to S&P Global's ratings oligopoly. 10 stocks we like better than AbbVie › ...